Procurement of Tislelitsumab (Tevimbra)
About This Opportunity
HUS Group Finland: Tislelitsumabin (Tevimbra). Supplies contract awarded, healthcare. Awarded to BeOne Medicines, GmbH, Dutch Branch (EUR 1.0M, May 2026).
This is a supplies contract in the health and medical services sector. Located in Finland, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from fiTislelitsumab is a humanized monoclonal antibody variant of immunoglobulin G4 (IgG4) against PD-1. It binds to the extracellular domain of human PD-1 and competitively inhibits the binding of both PD-L1 and PD-L2. According to the recommendation of the Health Care Service Selection Council (Palko) (8.5.2025), Tislelitsumab is included in the national service selection for the treatment of unresectable, locally advanced or metastatic esophageal squamous cell carcinoma in well-conditioned (ECOG 0-1) adult patients after previous platinum-based chemotherapy, in patients with PD-L1 expression ≥ 10%. Inclusion in the service selection requires the marketing authorization holder and the buyer to agree on a price significantly lower than the public wholesale price. The procurement ring includes HUS Group (HUS) and the owner members of the HUS Group (City of Helsinki, Eastern Uusimaa Wellbeing Services County, Central Uusimaa Wellbeing Services County, Vantaa and Kerava Wellbeing Services County, and Western Uusimaa Wellbeing Services County), South Karelia Wellbeing Services County, Kymenlaakso Wellbeing Services County, and Päijät-Häme Wellbeing Services County, as well as the Northern Finland cooperation area drug procurement ring (North Ostrobothnia Wellbeing Services County, Central Ostrobothnia Wellbeing Services County, Lapland Wellbeing Services County, and Kainuu Wellbeing Services County) authorized by HUS Pharmacy, the Eastern Finland cooperation area drug procurement ring (North Savo Wellbeing Services County, North Karelia Wellbeing Services County, South Savo Wellbeing Services County, and Central Finland Wellbeing Services County), and the Inner Finland cooperation area drug procurement ring (Pirkanmaa Wellbeing Services County, Kanta-Häme Wellbeing Services County, and South Ostrobothnia Wellbeing Services County).
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on May 15, 2026. Last refreshed 29 days ago. Original language: fi. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About HUS Group, the joint authority for Helsinki and Uusimaa
HUS Group, the joint authority for Helsinki and Uusimaa has issued 10 procurement notices on BidsFactory, including 2 currently open and 5 awarded contracts. Activity concentrates in Health & Medical, Governance & Public Administration, and General Supplies & Services. All notices are published for Finland. Notices are distributed via Hilma Finland and TED - Tenders Electronic Daily (EU). Most recent publication: May 24, 2026.
Frequently asked questions about this tender
Is this tender still open?
No — the contract has already been awarded to BeOne Medicines, GmbH, Dutch Branch. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by HUS Group, the joint authority for Helsinki and Uusimaa in Finland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
BeOne Medicines, GmbH, Dutch Branch was awarded the contract for €1,000,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Finland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.